Lexapro

The prescription antidepressant medication, Lexapro, has been linked to birth defects in newborn children.

Research studies have found that mothers taking Lexapro during their pregnancy – especially in the third trimester – have an increased risk of giving birth to children with health problems.

What Is Lexapro?

Lexapro, sold generically as escitalopram, is part of the antidepressant drug class known as Selective Serotonin Reuptake Inhibitors (SSRIs), sometimes also referred to as Serotonin-Specific Reuptake Inhibitors. SSRIs work by inhibiting the re-absorption of certain neurotransmitters produced by the body – in this case, serotonin – and stimulating the body’s receptors in the process.

How Can Lexapro Lead to Birth Defects?

Studies have found that mothers taking Lexapro and other SSRI drugs during their pregnancy have a slightly increased chance of having a baby with birth defects. Specifically, the risk of heart problems and cardiac defects is increased for a newborn whose mother was taking Lexapro while the child was in utero.

What Types of Birth Defects Could be Caused by Lexapro and SSRIs?

Congenital Heart Defects
Conotruncal Defects
Craniosynostosis
Omphalocele
Septal Defects
Ventricular Obstruction
And many more birth defects including cleft lip, clubfoot, and others

What do I do if My Child Has Been Injured by Lexapro?

If your child has been born with birth defects and you were taking Lexapro during any term of your pregnancy, contact our experienced Pennsylvania drug injury lawyers today. We’re not afraid to stand up to the big pharmaceutical companies that manufacture dangerous drugs. We’ll help you fight for your right to fair compensation.

Our law firm has been representing the injured residents of Pennsylvania and beyond for over 25 years. We know about the pain and frustration caused by drug injuries, especially when that victim is your newborn son or daughter. If your child has been hurt by Lexapro, take advantage of our free legal evaluation and contact our law firm right away.